Skip to main content

CommunicationPublished on 12 May 2021

«Taking part in this global effort is in Switzerland's direct interest»

Switzerland is engaged in the global coronavirus pandemic response through its support for the Access to COVID-19 Tools (ACT-A) Accelerator. The tools needed to overcome this crisis are clear: tests, medicines and vaccines. The top priority is too: to ensure everyone has equitable access to medical resources. For an in-depth look at this issue, we spoke with Christian Frutiger, Head of Global Cooperation at the Swiss Agency for Development and Cooperation (SDC). He shares with us his first-hand experience with ACT-A in the area of diagnostics.

The ACT-A initiative aims to develop vaccines, medicines and tests and strengthen healthcare systems worldwide.
The ACT-A initiative is a remarkable and unprecedented collective response to this type of challenge.
Christian Frutiger
ACT-A objectives are ambitious but, we believe, attainable if all public and private actors, as well as research centres and institutions around the world, work together.
Christian Frutiger
As Dr Tedros Ghebreyesus, Director-General of the WHO, has reminded us regularly since the crisis began: no one is safe until everyone is safe.
Christian Frutiger

Contact

Swiss Agency for Development and Cooperation (SDC)
Eichenweg 5
3003 Bern